21 November 2017
News and Views
Links and Services
Infliximab is effective in the treatment of Crohn's disease and ulcerative colitis in children and adolescents, reports a team of doctors in June's Journal of Pediatric Gastroenterology & Nutrition.
Dr Vera Lucia and colleagues from India evaluated the response to infliximab in
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors